These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 18055041)
1. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation. Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919 [TBL] [Abstract][Full Text] [Related]
4. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428 [TBL] [Abstract][Full Text] [Related]
5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525 [TBL] [Abstract][Full Text] [Related]
7. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998 [TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure. Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population. Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472 [TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710 [TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related]
13. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation. Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612 [TBL] [Abstract][Full Text] [Related]
14. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications? Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108 [TBL] [Abstract][Full Text] [Related]
15. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation. Petracca F; Affuso F; Di Conza P; Micillo F; Castellano G; Guardasole V; Scopacasa F; Saccà L; Fazio S J Cardiovasc Med (Hagerstown); 2009 Dec; 10(12):928-32. PubMed ID: 19606057 [TBL] [Abstract][Full Text] [Related]
17. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related]
18. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777 [TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation. Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616 [TBL] [Abstract][Full Text] [Related]
20. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]